<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-14-68-b</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-14-9-7</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Toxic-Metabolic Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Celiac Antibodies and Neurologic Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>09</month>
<year>2000</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>04</month>
<year>2016</year>
</pub-date>
<volume>14</volume>
<issue>9</issue>
<fpage>68</fpage>
<lpage>69</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2000 The Author(s)</copyright-statement>
<copyright-year>2000</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/S0887-8994(00)00129-6" vol="22" page="393">
<article-title>Prevalence of celiac antibodies in children with neurologic disorders</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The yield of screening for celiac disease in children with common neurologic disorders was evaluated at Tel Aviv University, Zerifin, Israel.</p>
</abstract>
<kwd-group>
<kwd>Celiac Disease</kwd>
<kwd>Neurologic Disorders</kwd>
<kwd>Motor Abnormalities</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The yield of screening for celiac disease in children with common neurologic disorders was evaluated at Tel Aviv University, Zerifin, Israel. Of 167 patients presenting, ages 1 to 16 years, 41 had migraine headaches, 39 ADHD, 36 epilepsy, and 51 hypotonia and motor abnormalities. IgG antigliadin antibodies were positive in 22 (13%) of patients compared to 3 (9%) in the control group. IgA and endomysial antibodies were negative in all patients, and duodenal biopsies were not performed. Routine screening for celiac disease is not recommended in children presenting wsith common neurologic disorders. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMON. Neurologic complications of celiac disease include peripheral neuropathy, myopathy, cerebellar ataxia, myoclonus, cerebral atrophy, cerebral vasculitis, encephalitis, epilepsy, sometimes associated with cerebral calcification. Studies in adults have shown a significant increase in positive titers for antigliadin antibodies in patients (57%) with common neurologic disorders of undetermined etiology. In children, the association of celiac disease with common neurologic disorders is apparently less remarkable. However, in patients with ataxia, myopathy, or seizures of undetermined etiology, a test for antigliadin antibodies should be considered, especially as symptoms may be reversible with a gluten-free diet.</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahat</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Broide</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Leshem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Scapa</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Prevalence of celiac antibodies in children with neurologic disorders</article-title>
<source>Pediatr Neurol</source>
<year>2000</year>
<month>May</month>
<volume>22</volume>
<issue>5</issue>
<fpage>393</fpage>
<lpage>396</lpage>
<pub-id pub-id-type="doi">10.1016/S0887-8994(00)00129-6</pub-id>
<pub-id pub-id-type="pmid">10913732</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>